Brief Summary

The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management. .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

October 22, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 21, 2015

Completed
Last Updated

July 30, 2018

Status Verified

April 1, 2015

Enrollment Period

3.3 years

First QC Date

October 22, 2014

Last Update Submit

July 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • COPD Assessment Test (CAT)

    COPD related quality of life measure in primary care.

    1 Year

Secondary Outcomes (3)

  • Health Care Utilization for Emergency Department visits proportion and rate per year

    1 year

  • Health Care Utilization for Hospital Admission proportion and rate per year

    1 year

  • Severe Exacerbation proportion and rate per year

    1 year

Other Outcomes (8)

  • Quality of Life

    1 year

  • Improvement in Knowledge of COPD and confidence in self-management

    1 year

  • Process of Care

    1 year

  • +5 more other outcomes

Study Arms (2)

Case Management and Self-Management Education

EXPERIMENTAL

A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician. Specific elements of evidence-based management are targetted for intervention. Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months. Telephone follow up will occur at a minimum at 6 and 9 months.

Other: Case Management and Self-Management Education

Usual Care

PLACEBO COMPARATOR

A Certified Respiratory Educator (CRE) will meet with subjects to obtain a detailed COPD history and do a breathing test. Subjects will receive COPD care as usually provided by their physician.

Other: Case Management and Self-Management Education

Interventions

A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician. Specific elements of evidence-based management are targetted for intervention. Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months. Telephone follow up will occur at a minimum at 6 and 9 months.

Case Management and Self-Management EducationUsual Care

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current or Ex-smokers
  • years of age or over
  • Minimum 10 pack year smoking history
  • Post-bronchodilator FEV1 of 70% or less (4 puffs of Salbutamol) and Forced Expiratory Volume at 1sec to Forced Vital Capacity (FEV1/FVC) ratio 70% or less
  • A history of two exacerbations (involving treatment and/or visit to a health care practitioner) in the past 3 years OR 1 exacerbation in the past year
  • Provides informed consent

You may not qualify if:

  • COPD exacerbation in the past 4 weeks
  • Diagnosis of asthma prior to the age of 40 years
  • Co-existing illness that could interfere with study results (ie. Congestive Heart Failure with exacerbation of symptoms)
  • Scheduled for COPD rehabilitation
  • A terminal illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Amherstburg FHT

Amherstburg, Ontario, N9V 0B4, Canada

Location

Chatham-Kent FHT

Chatham, Ontario, N7L 5K5, Canada

Location

Harrow FHT

Harrow, Ontario, NOR 1G0, Canada

Location

Leamington FHT

Leamington, Ontario, N8H 1N8, Canada

Location

Related Publications (1)

  • Ferrone M, Masciantonio MG, Malus N, Stitt L, O'Callahan T, Roberts Z, Johnson L, Samson J, Durocher L, Ferrari M, Reilly M, Griffiths K, Licskai CJ; Primary Care Innovation Collaborative. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med. 2019 Mar 28;29(1):8. doi: 10.1038/s41533-019-0119-9.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Case Management

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Christopher Licskai

    Lawson Health Research Institution

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2014

First Posted

January 21, 2015

Study Start

October 1, 2011

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

July 30, 2018

Record last verified: 2015-04

Data Sharing

IPD Sharing
Will not share

Locations